Information about Flixabi (Infliximab)
Flixabi is a biosimilar medication to infliximab, which is a monoclonal antibody used to treat various autoimmune conditions. It functions by inhibiting tumor necrosis factor-alpha (TNF-alpha), a substance in the body that plays a role in inflammation.
Product Highlights
- Management of moderate to severe rheumatoid arthritis.
- Treatment of Crohn's disease and ulcerative colitis.
- Treatment of psoriasis and psoriatic arthritis.
- Indicated for ankylosing spondylitis.
Key Ingredient
Key Benefits
- Helps alleviate symptoms of inflammatory conditions.
- Can lead to significant improvement in patients' daily activities and overall well-being.
- Supports chronic disease management, potentially reducing the need for corticosteroids.
Direction of Use
- Ensure that the infusion area is clean and that all necessary equipment is ready.
- Flixabi is typically administered as an intravenous infusion, often over a period of 2 hours.
- Patients should be monitored during and after infusion for any adverse reactions.
Safety Concerns
- May include infusion reactions, infections, headache, and gastrointestinal symptoms.
- Patients may be at higher risk for serious infections due to immunosuppression.
- Blood tests may be needed to monitor for potential adverse effects, including liver function and blood cell counts.
Avoid Flixabi (Infliximab) If
- You have a known allergy to infliximab or any of its components.
- You have a current or history of serious infections, including tuberculosis.
- You are pregnant or breastfeeding without consulting your healthcare provider.
This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees Celsius, and contact the pharmacy immediately.
